Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06863337 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 23, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Primary completion date: Dec 31, 2025 to Jun 30, 2026 Enrollment target: 80 to 100 · Completion date: Apr 30, 2026 to Apr 30, 2027v4 Show 2 more changesShow less
    • Enrollment target: 80 to 100
    • Completion date: Apr 30, 2026 to Apr 30, 2027
  3. Trial status: Not Yet Recruiting to Recruiting Eligibility criteria expanded, about 11 words · Site details revisedv3 Show 2 more changesShow less
    • Eligibility criteria expanded, about 11 words
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  4. Start date: Apr 1, 2025 to Mar 26, 2025v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
No studies have been seen on glucose variation during medication for assisted reproduction. The aim of this study is to continuously observe glucose variation during assisted reproduction treatment using continuous glucose monitoring (CGM), and to further explore whether glucose variation will affect the outcomes related to assisted reproduction.
Trial Details
NCT Number NCT06863337
Lead Sponsor Shanghai 6th People's Hospital
Conditions Infertility Female
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov